BluePath SolutionsBluePath Solutions
Search
  • Home
  • About
  • Solutions
    • Our approach
    • Value Marketing & Communications
    • Modeling & Data Visualization
    • Health Economics & Outcomes Research
  • The Compass
  • Careers
  • Contact us
  • Home
  • Medicare Part D Direct & Indirect Remuneration
  • Featured

Featured

14OctOctober 14, 2021

Medicare Part D Direct & Indirect Remuneration

admin2021-10-15T08:52:09+00:00

Payers who offer Medicare Part D plans may receive additional compensation after the point-of-sale. These funds are known as Direct & Indirect Remuneration (DIR), and account for growing levels of...

By adminBlog, FeaturedComments Off
Read more...
27FebFebruary 27, 2019

Overview of Proposed Rule Changes to “Safe Harbor” Regulation

admin2021-10-15T11:27:55+00:00

Health and Human Services (HHS) is proposing to eliminate safe harbor protection for manufacturer reductions in price on prescription pharmaceutical products to Medicare Part D plans, PBM’s, and Medicaid Managed...

By adminBlog, FeaturedComments Off
Read more...
27MayMay 27, 2018

CAR-T Commercial Market Access Brief – A Review of Initial Brand Access at Select US Payers

admin2021-10-15T11:28:35+00:00

Chimeric Antigen Receptor T-cell (CAR-T) therapies represent a breakthrough in cancer care due to the significant clinical response induced in patients who do not respond to currently available treatments. In...

By adminBlog, FeaturedComments Off
Read more...
15MayMay 15, 2018

A Snapshot of the Conclusions on Long-term Value of Healthcare Treatments Conducted by the Institute for Clinical and Economic Review Group

admin2021-10-15T11:29:34+00:00

The Institute for Clinical and Economic Review, a non-profit institute evaluates the cost-effectiveness of drugs, medical devices, medical procedures, and diagnostics. The Institute for Clinical and Economic Review has published...

By adminBlog, FeaturedComments Off
Read more...
01NovNovember 1, 2017

US Market Access – Key Considerations in a Changing Environment

admin2021-10-15T11:30:13+00:00

Many life science manufacturers employ a payer size and control strategy in the US market. While this continues to be viable model, changes in formulary and benefit design result in...

By adminBlog, FeaturedComments Off
Read more...
02OctOctober 2, 2017

Emerging Barriers to Launch Access – the Impact of New Drug Coverage Policies

admin2021-10-14T05:37:09+00:00

New drug coverage policies provide guidance around a payer’s coverage of new drugs in the time period between FDA approval and P&T committee review. As these policies proliferate, manufacturers may...

By adminBlog, FeaturedComments Off
Read more...

Recent Posts

14OctOctober 14, 2021

Medicare Part D Direct & Indirect Remuneration

Payers who offer Medicare Part D plans may receive additional compensation after the point-of-sale. These... read more

27FebFebruary 27, 2019

Overview of Proposed Rule Changes to “Safe Harbor” Regulation

Health and Human Services (HHS) is proposing to eliminate safe harbor protection for manufacturer reductions... read more

27MayMay 27, 2018

CAR-T Commercial Market Access Brief – A Review of Initial Brand Access at Select US Payers

Chimeric Antigen Receptor T-cell (CAR-T) therapies represent a breakthrough in cancer care due to the... read more

15MayMay 15, 2018

A Snapshot of the Conclusions on Long-term Value of Healthcare Treatments Conducted by the Institute for Clinical and Economic Review Group

The Institute for Clinical and Economic Review, a non-profit institute evaluates the cost-effectiveness of drugs,... read more

01NovNovember 1, 2017

US Market Access – Key Considerations in a Changing Environment

Many life science manufacturers employ a payer size and control strategy in the US market.... read more

  • Home
  • About
  • Solutions
  • The Compass
  • Careers

Contact us

1640 S Sepulveda Blvd, Suite 207
Los Angeles, CA 90025
United States

855.378.4115
310.774.0406

Follow BPS

Linkedin
veeva logo
hippa logo

©2021 BluePath Solutions, All Rights Reserved

  • Privacy Policy
  • Terms
BluePath Solutions © Copyright 2021. All Rights Reserved.
  • Home
  • About
  • Solutions
    • Our approach
    • Value Marketing & Communications
    • Modeling & Data Visualization
    • Health Economics & Outcomes Research
  • The Compass
  • Careers
  • Contact us
Cleantalk Pixel